Relationship between prodynorphin ( PDyn ) gene expression and phosphoprotein ( DARPP-32 )phosphorylation in rats with levodopa-induced dyskinesias

Qiang GUAN,Xue-bing CAO,Yan XU,Lan WANG,Sheng-gang SUN
DOI: https://doi.org/10.3760/j.issn:1006-7876.2006.07.011
2006-01-01
Abstract:Objective: To study the changes of prodynorphin(PDyn) gene expression and dopamine and cAMP-regulated phosphoprotein (DARPP-32) phosphorylation and to explore the mechanism of over-activation in direct-pathway in rats with levodopa-induced dyskinesias(LID). Methods: 6-OHDA rat models received twice levodopa celiac (10 mg/kg) injections daily for 28 days to get LID rats. The normal rats received same course and dosage of levodopa as a control group. Hybridization in situ was used to measure the expression of PDyn mRNA in striatum. Protein and mRNA levels of total DARPP-32 and phospho-Thr-34 DARPP-32 levels were measured by immunoblotting and reverse transcriptase-polymerase chain reaction (RT-PCR), respectively. Results: The levels of PDyn mRNA in LID group (0. 3662 ± 0.0625) was increased significantly compared to those of control (0. 2085 ± 0. 0573) and levodopa treatment group (0.2235 ± 0.0582) (P < 0. 01, respectively). Phospho-Thr-34 DARPP-32 expression in LID group (1075. 2 ± 103. 3) increased significantly compared to controls(198. 7 ± 49. 5) and levodopa treatment group (213. 9 ± 58. 9) (P < 0. 01, respectively). Conclusion: Phospho-Thr-34 DARPP-32 level is increased in LID rats, which contributes to the over-activation in direct-pathway.
What problem does this paper attempt to address?